Vaccination and modern management of chronic obstructive pulmonary disease – a narrative review
Authors:
- 3 June 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 16 (6) , 605-614
Abstract
Chronic obstructive pulmonary disease (COPD) carries a tremendous societal and individual burden posing significant challenges for public health systems worldwide due to its high morbidity and mortality. Due to aging, multimorbidity but also in the wake of important progress in deciphering the heterogeneous disease endotypes, an individualized approach to the prevention and management of COPD is necessary. This article tackles relevant immunization strategies that are available or still under development with a focus on latest evidence but also controversies around different regional immunization approaches. Further, we present the crossover between chronic lung inflammation and lung microbiome disturbance as well as its role in delineating COPD endotypes. Moreover, the article attempts to underline endotype-specific treatment approaches. Lastly, we highlight non-pharmacologic prevention and management programs in view of the challenges and opportunities of the COVID-19 era. Despite remaining challenges, personalised medicine has the potential to offer tailored approaches to prevention and therapy and promises to improve the care of patients living with COPD.Keywords
This publication has 132 references indexed in Scilit:
- Risk factors for community-acquired pneumonia in adults in Europe: a literature reviewThorax, 2013
- Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax, 2012
- A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit DatesNicotine & Tobacco Research, 2011
- Azithromycin for Prevention of Exacerbations of COPDNew England Journal of Medicine, 2011
- Efficacy of Varenicline to Prompt Quit Attempts in Smokers Not Currently Trying to Quit: A Randomized Placebo-Controlled TrialNicotine & Tobacco Research, 2011
- Prevalence of viral infection detected by PCR and RT‐PCR in patients with acute exacerbation of COPD: A systematic reviewRespirology, 2010
- COPD-related morbidity and mortality after smoking cessation: status of the evidenceEuropean Respiratory Journal, 2008
- COPD exacerbations: defining their cause and preventionThe Lancet, 2007
- Risk of hospitalization during influenza season among a cohort of patients with congestive heart failureEpidemiology and Infection, 2006
- Respiratory Syncytial Virus Infection in Elderly and High-Risk AdultsNew England Journal of Medicine, 2005